| Dr Robert Joseph Gogan, MD | |
|
10945 N Port Washington Rd, Suite 211, Mequon, WI 53092-5078 | |
| (262) 241-8000 | |
| (262) 241-8096 |
| Full Name | Dr Robert Joseph Gogan |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 49 Years |
| Location | 10945 N Port Washington Rd, Mequon, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366434086 | NPI | - | NPPES |
| 040004274 | Other | WI | RRB |
| 30326800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 22771-020 (Wisconsin) | Primary |
| 207YS0123X | Otolaryngology - Facial Plastic Surgery | 222771 (Wisconsin) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Milwaukee Ear Nose Throat Clinic Limited | 2466472964 | 3 |
News Archive
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer.
The global war on smoking has been given a major boost with Australia's ratification on 27 October 2004 of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC).
A new study by Rice University's Baker Institute for Public Policy illustrates a disconnect between government funding of biomedical research by young investigators and a novel standard by which to judge it: the Nobel Prize.
Sandoz was pleased to learn this week that the U.S. Court of Appeals in St. Louis has affirmed a summary judgment by U.S. District Judge Rodney Sippel invalidating patent protection on Toprol XL(R), a beta blocker used to treat angina, heart failure, and high blood pressure.
› Verified 5 days ago
| Entity Name | Milwaukee Ear Nose Throat Clinic Limited |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457497091 PECOS PAC ID: 2466472964 Enrollment ID: O20051129000776 |
News Archive
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer.
The global war on smoking has been given a major boost with Australia's ratification on 27 October 2004 of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC).
A new study by Rice University's Baker Institute for Public Policy illustrates a disconnect between government funding of biomedical research by young investigators and a novel standard by which to judge it: the Nobel Prize.
Sandoz was pleased to learn this week that the U.S. Court of Appeals in St. Louis has affirmed a summary judgment by U.S. District Judge Rodney Sippel invalidating patent protection on Toprol XL(R), a beta blocker used to treat angina, heart failure, and high blood pressure.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Joseph Gogan, MD 10945 N Port Washington Rd, Suite 211, Mequon, WI 53092-5078 Ph: (262) 241-8000 | Dr Robert Joseph Gogan, MD 10945 N Port Washington Rd, Suite 211, Mequon, WI 53092-5078 Ph: (262) 241-8000 |
News Archive
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer.
The global war on smoking has been given a major boost with Australia's ratification on 27 October 2004 of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC).
A new study by Rice University's Baker Institute for Public Policy illustrates a disconnect between government funding of biomedical research by young investigators and a novel standard by which to judge it: the Nobel Prize.
Sandoz was pleased to learn this week that the U.S. Court of Appeals in St. Louis has affirmed a summary judgment by U.S. District Judge Rodney Sippel invalidating patent protection on Toprol XL(R), a beta blocker used to treat angina, heart failure, and high blood pressure.
› Verified 5 days ago
Dr. Andrew C Campbell, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 10604 N Port Washinton Rd, Mequon, WI 53092 Phone: 262-242-7772 Fax: 262-478-0884 | |
Russell Steven Yale, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 10520 N. Port Washington Rd., Mequon, WI 53092 Phone: 262-240-0705 Fax: 262-240-0759 | |
Jolene E. Andryk, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 12203 Corporate Pkwy, Mequon, WI 53092 Phone: 262-387-8200 Fax: 262-387-8271 | |
James L Rossiter, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 10610 N Port Washington Road, Mequon, WI 53092 Phone: 414-771-6780 Fax: 414-238-2424 | |
Richard N Schmidt, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 10610 N Port Washington Rd, Mequon, WI 53092 Phone: 414-771-6780 Fax: 414-238-2424 |